GlassScriptPhysician profile
Tamar B Hanfling
NPI 1073683280
$2,604.84
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,727 · 2020: $537 · 2021: $46.21 · 2022: $48.96 · 2023: $162 · 2024: $83.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $457.19 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $233.41 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $227.07 | 2019-2020 | |
| Abbvie INC. | $216.78 | 2022-2024 | |
| Lundbeck LLC | $191.77 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $173.38 | 2019-2020 | |
| Tris Pharma INC | $153.86 | 2020-2023 | Dyanavel Xr |
| Shire North American Group INC | $147.44 | 2019 | |
| Neurocrine Biosciences, INC. | $138.04 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $109.36 | 2019-2024 | Fanapt |
| Avanir Pharmaceuticals, INC. | $100.19 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $87.94 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $50.14 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $49.10 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $46.57 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $43.55 | 2019 | |
| Janssen Pharmaceuticals, INC | $40.20 | 2019 | |
| Corium, LLC | $26.59 | 2024 | Azstarys |
| Eisai INC. | $23.24 | 2020 | |
| Alfasigma USA, INC. | $20.09 | 2020 | |
| Vertical Pharmaceuticals, LLC | $16.43 | 2019 | |
| Rhodes Pharmaceuticals L.P. | $15.09 | 2019 | |
| Harmony Biosciences LLC | $14.05 | 2020 | |
| Lilly USA, LLC | $12.48 | 2019 | |
| Arbor Pharmaceuticals, INC. | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamar Hanfling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.